Molecular docking between the four active compounds of MCE and the five core targets was performed based on the results of the aforementioned analysis: the ligands were SAN, CHE, PRO, and ALL, and the receptors were HSP90AA1 (PDB ID: 7S9H), MAPK1 (PDB ID: 6G54), HRAS (PDB ID: 7JII), JAK2 (PDB ID: 7F7W), and AKT1 (PDB ID: 7NH5). This evidence concerns the gene MAPK1 and acute lymphoblastic leukemia.